)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Materialise
Materialise (MTLS) investor relations material
Materialise Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary28 Oct, 2026
Executive summary
Q3 revenue rose 2.1% YoY to €67.670M; growth was 4.9% excluding recent divestitures.
Medical revenue grew 9.7%; Manufacturing grew 1.5% excluding divestitures. Net profit was €1.383M.
Net cash reached €82.473M, up €11.668M from year-end 2025.
Financial highlights
Gross profit rose 3.7% to €39.035M; gross margin was 57.7%, up 90 bps YoY.
Adjusted EBIT was €2.485M vs. €2.918M; Adjusted EBITDA was €8.046M vs. €8.428M.
Operating profit was €1.343M vs. €2.522M; net profit was €1.383M vs. €1.848M, with diluted EPS of €0.02 vs. €0.03.
R&D, sales and marketing, and G&A expenses rose 7.8% to €38.830M, driven mainly by 11.9% higher R&D spending.
Outlook and guidance
FY26 revenue guidance of €273M–€283M and Adjusted EBIT guidance of €12M–€14M were reaffirmed, absorbing the impact of RapidFit and Eyewear divestitures.
Priorities include strategy execution, targeted investment, cost control and cash generation.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Materialise
- FY revenue and adjusted EBITDA grew; 2024 revenue guidance is €265–275m.MTLS
Q4 2023 - Q2 2026 revenue up 8.1%, net profit surged, and full-year EBIT guidance was raised.MTLSQ2 2026
- Stable revenue and improved profitability in Q1 2026 support reaffirmed full-year guidance.MTLSQ1 2026
- Q4 revenue up 6.8%, Medical segment leads, 2026 EBIT guided at EUR 10–12 million.MTLSQ4 2025
- Medical segment growth offsets overall revenue decline; cost control sustains profitability.MTLSQ2 2025
- Q3 2024 revenue up 14.2% to €68.7M, led by Medical; full-year outlook reaffirmed.MTLSQ3 2024
- Record Q2 revenue and profit, led by Medical growth and strategic medical technology expansion.MTLSQ2 2024
- Medical segment drove 4.3% revenue growth, but profits fell; 2025 guidance unchanged.MTLSQ1 2025
- Medical growth drove profit gains, but Manufacturing and Software faced headwinds in 2024.MTLSQ4 2024
Next Materialise earnings date
Q4 202622 Apr, 2027
Materialise
Next Materialise earnings date
Q4 202622 Apr, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Materialise NV provides services and software for additive manufacturing, 3D printing and aiding medical research. The company develops its products and services following a procedure known as the 'Bespoke Approach', which aims to give its customers the best possible individual service. By using the latest technology and techniques, Materialise NV are able to deliver products of the highest quality. Materialise NV is based in Leuven, Belgium.